Further studies showed that S1P/S1pr1 praxis activated AKT/eNOS signalling pathways and enhanced the production of NO, which contributed to the protective effect of EC‐S1pr1 on cardiac hypertrophy and fibrosis. This evidence concerns the gene NOS3 and cardiac hypertrophy.